Introduction:

Phosphorylation is one of the most important PTMs in a biological system. This service can be used to study the phosphorylated proteins in your biological samples. Phosphorylated proteins/peptides will be enriched and then subject to downstream proteome identification or quantification through Mass Spectrometry Analysis. Total phosphorylation proteome (through TiO2 enrichment) and specific targeted phosphorylation proteome (through enrichment using anti-Phospho-Tyrosine or anti-Phospho-(Ser/Thr) Phe antibodies) can be analyzed to identify the phosphorylated proteins in your sample, and the difference in phosphorylation levels of proteins in your samples when combining with TMT or iTRAQ labeling strategy. Your samples (several test groups and a control group) will be digested with Trypsin, and peptides will be enriched using an appropriate method, followed by chemical labeling by either iTRAQ or TMT labeling method if a quantitative analysis is desired. Enriched (with or without labeling) peptideswill be cleaned using SCX HPLC and a bRPLC fraction to further generate the 2nd dimansion of separation which has been proved to significantly increase the coverage and depth of the Mass Spectrometry Analysis.

Data analysis, including data validation, visualization and quantification, are performed with commercial softwares and Complete Omics’ unique R packages and scripts. Report will be sent to you in Excel format as well as a summary in PDF format. We will also provide you any details you need for your papers’ MATERIALS AND METHODS section. We will make sure you understand your result and help you with your paper writing with free follow-up services.

Sample types we accept:

1, 2D gel spots, SDS-PAGE bands

2, Cell Lysates and Tissue Lysates

3, Biofluids, such as plasma*, serum*, saliva, tear, etc.

*We provide High Abundance Protein Depletion Service to significantly (100-500 folds) increase the depth of your biofluid proteomics analysis by removing top abundant proteins from your samples. Read more for details​.

4, FFPE slide/ FFPE extract

5, Customized sample types (please contact us to discuss)

Complete360® Enables Deep Biomarker Profiling in Groundbreaking iPSC CAR‑NK Cell Therapy Study Published in Cell

June 25, 2025 | BALTIMORE – We are thrilled to share that a major milestone in cell therapy has just been published in Cell, showcasing the world’s first-in-human clinical study of…

Read more

Complete Omics Makes Landmark Debut at ASMS 2025

June 5, 2025 | BALTIMORE -Complete Omics Inc. is proud to announce a successful debut at the American Society for Mass Spectrometry (ASMS) 2025 Annual Meeting, held in Baltimore, Maryland.

Read more

Milestone! | Complete Omics Inc. Secures California Clinical Laboratory License, Expanding Access to Cutting-Edge Clinical Proteomics Testing

Feb 20, 2025 | BALTIMORE – Complete Omics Inc., a leader in clinical proteomics and multi-omics molecular diagnostics, proudly announces its recent achievement of the California Clinical Laboratory License. This…

Read more

Some of our impacts